ScienceDex / Researcher record
Duckett, Derek Ronald
- Moffitt Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- R01 Holder
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2013 | $436,923 | 1 | #16,687 |
| 2014 | $381,842 | 1 | #19,888 |
| 2015 | $381,228 | 1 | #20,247 |
| 2017 | $598,284 | 1 | #13,860 |
| 2021 | $1,176,402 | 2 | #7,554 |
| 2022 | $1,257,452 | 4 | #7,282 |
| 2023 | $1,226,204 | 3 | #7,852 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20131 record
- FY20141 record
- FY20151 record
- FY20171 record
- FY20212 records
- FY20224 records
- FY2023 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Duckett, Derek Ronald as a PI. Multi-PI records show the full award amount for context.
- 5R01CA262530-03R01Contact PIDeveloping CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers$666.3Kaward amount
- 5R01CA233601-04R01Contact PITranscriptional and Epigenetic Adaptation as Novel Therapeutic Vulnerabilities for Mantle Cell Lymphoma$487.3Kaward amount
- 3R01CA262530-03S1R01Contact PIDeveloping CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers$72.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Duckett, Derek Ronald as a PI.
FY2023 award administered by Moffitt Cancer Center (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardMoffitt Cancer Center
- 2014$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015R01 Grant Holder
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #7554
- 2023$5M Cumulative Funding